These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 20851716

  • 1. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
    Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T.
    Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
    [Abstract] [Full Text] [Related]

  • 2. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J, Cheah CY, AbuBakar S.
    Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
    [Abstract] [Full Text] [Related]

  • 3. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR.
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [Abstract] [Full Text] [Related]

  • 4. 3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent.
    Hidari KI, Ikeda K, Watanabe I, Abe T, Sando A, Itoh Y, Tokiwa H, Morita K, Suzuki T.
    Biochem Biophys Res Commun; 2012 Aug 03; 424(3):573-8. PubMed ID: 22776202
    [Abstract] [Full Text] [Related]

  • 5. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA, Palanisamy UD, Tejo BA, Chew MF, Tham HW, Syed Hassan S.
    Virol J; 2017 Nov 21; 14(1):229. PubMed ID: 29162124
    [Abstract] [Full Text] [Related]

  • 6. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
    Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, Schols D.
    Virology; 2009 Apr 25; 387(1):67-75. PubMed ID: 19264337
    [Abstract] [Full Text] [Related]

  • 7. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.
    Limjindaporn T, Wongwiwat W, Noisakran S, Srisawat C, Netsawang J, Puttikhunt C, Kasinrerk W, Avirutnan P, Thiemmeca S, Sriburi R, Sittisombut N, Malasit P, Yenchitsomanus PT.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):196-200. PubMed ID: 19105951
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1.
    Jinno-Oue A, Tanaka A, Shimizu N, Mori T, Sugiura N, Kimata K, Isomura H, Hoshino H.
    AIDS Res Hum Retroviruses; 2013 Mar 06; 29(3):621-9. PubMed ID: 23033806
    [Abstract] [Full Text] [Related]

  • 9. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
    Talarico LB, Pujol CA, Zibetti RG, Faría PC, Noseda MD, Duarte ME, Damonte EB.
    Antiviral Res; 2005 Jun 06; 66(2-3):103-10. PubMed ID: 15911027
    [Abstract] [Full Text] [Related]

  • 10. [Selection of heparin-sensitive dengue virus variants in BHK-21 cells].
    Celis A, Moros Z, Gerder M, Pagano F, Vizzi E, Liprandi F.
    Invest Clin; 2014 Jun 06; 55(2):155-67. PubMed ID: 24974631
    [Abstract] [Full Text] [Related]

  • 11. A small molecule fusion inhibitor of dengue virus.
    Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W.
    Antiviral Res; 2009 Dec 06; 84(3):260-6. PubMed ID: 19800368
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the steps involved in Dengue virus entry into host cells.
    Hung SL, Lee PL, Chen HW, Chen LK, Kao CL, King CC.
    Virology; 1999 Apr 25; 257(1):156-67. PubMed ID: 10208929
    [Abstract] [Full Text] [Related]

  • 13. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
    Alen MM, Dallmeier K, Balzarini J, Neyts J, Schols D.
    Antiviral Res; 2012 Dec 25; 96(3):280-7. PubMed ID: 23124109
    [Abstract] [Full Text] [Related]

  • 14. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT.
    Chem Biol Drug Des; 2015 Nov 25; 86(5):1093-104. PubMed ID: 25891143
    [Abstract] [Full Text] [Related]

  • 15. An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection.
    Talarico LB, Duarte ME, Zibetti RG, Noseda MD, Damonte EB.
    Planta Med; 2007 Nov 25; 73(14):1464-8. PubMed ID: 17948168
    [Abstract] [Full Text] [Related]

  • 16. Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors.
    Marks RM, Lu H, Sundaresan R, Toida T, Suzuki A, Imanari T, Hernáiz MJ, Linhardt RJ.
    J Med Chem; 2001 Jun 21; 44(13):2178-87. PubMed ID: 11405655
    [Abstract] [Full Text] [Related]

  • 17. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry.
    Gao F, Duan X, Lu X, Liu Y, Zheng L, Ding Z, Li J.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):952-7. PubMed ID: 19962368
    [Abstract] [Full Text] [Related]

  • 18. Peptide inhibitors against dengue virus infection.
    Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT.
    Chem Biol Drug Des; 2014 Aug 01; 84(2):148-57. PubMed ID: 24612829
    [Abstract] [Full Text] [Related]

  • 19. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
    Mondotte JA, Lozach PY, Amara A, Gamarnik AV.
    J Virol; 2007 Jul 01; 81(13):7136-48. PubMed ID: 17459925
    [Abstract] [Full Text] [Related]

  • 20. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
    Rees CR, Costin JM, Fink RC, McMichael M, Fontaine KA, Isern S, Michael SF.
    Antiviral Res; 2008 Nov 01; 80(2):135-42. PubMed ID: 18606464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.